{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:45:18Z","timestamp":1789055118931,"version":"build-2803163510"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10,1]]},"DOI":"10.2146\/ajhp150425","type":"journal-article","created":{"date-parts":[[2016,9,19]],"date-time":"2016-09-19T11:54:07Z","timestamp":1474286047000},"page":"1508-1511","source":"Crossref","is-referenced-by-count":4,"title":["Evidence of a clinically significant interaction between warfarin and intravesical gemcitabine"],"prefix":"10.1093","volume":"73","author":[{"given":"Kari","family":"Kurtzhalts","sequence":"first","affiliation":[{"name":"Veterans Affairs Western New York Healthcare System, Buffalo, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.","family":"Gee","sequence":"additional","affiliation":[{"name":"Veterans Affairs Western New York Healthcare System, Buffalo, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Feuz","sequence":"additional","affiliation":[{"name":"Buffalo General Medical Center, Buffalo, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin C.","family":"Krajewski","sequence":"additional","affiliation":[{"name":"Veterans Affairs Western New York Healthcare System, Buffalo, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041103105117900_b1-0731508","volume-title":"Coumadin (warfarin sodium) package insert","year":"1954"},{"issue":"suppl","key":"key\n\t\t\t\t2019041103105117900_b2-0731508","doi-asserted-by":"crossref","first-page":"e44S","DOI":"10.1378\/chest.11-2292","article-title":"Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Ageno","year":"2012","journal-title":"Chest"},{"key":"key\n\t\t\t\t2019041103105117900_b3-0731508","volume-title":"Gemzar (gemcitabine) package insert","year":"1996"},{"key":"key\n\t\t\t\t2019041103105117900_b4-0731508","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1592\/phco.19.16.1331.30873","article-title":"Identification of a gemcitabine-warfarin interaction","volume":"19","author":"Kinikar","year":"1999","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t2019041103105117900_b5-0731508","first-page":"434","article-title":"Interaction between gemcitabine and warfarin causing gastrointestinal bleeding in a patient with pancreatic cancer","volume":"5","author":"Saif","year":"2005","journal-title":"J Appl Res"},{"key":"key\n\t\t\t\t2019041103105117900_b6-0731508","first-page":"739","article-title":"Interaction between capecitabine and gemcitabine with warfarin in a patient with pancreatic cancer","volume":"9","author":"Saif","year":"2008","journal-title":"JOP"},{"key":"key\n\t\t\t\t2019041103105117900_b7-0731508","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.juro.2007.09.003","article-title":"Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update","volume":"178","author":"Hall","year":"2007","journal-title":"J Urol"},{"key":"key\n\t\t\t\t2019041103105117900_b8-0731508","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/j.1875-9114.1997.tb03782.x","article-title":"A review of enzyme induction of warfarin metabolism with recommendations for patient management","volume":"17","author":"Cropp","year":"1997","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t2019041103105117900_b9-0731508","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1345\/aph.1H423","article-title":"Proposal for a new tool to evaluate drug interaction cases","volume":"41","author":"Horn","year":"2007","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t2019041103105117900_b10-0731508","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1200\/JCO.2003.09.028","article-title":"Intravesical gemcitabine therapy for superficial transitional cell carcinoma of the bladder: a phase I and pharmacokinetic study","volume":"21","author":"Laufer","year":"2003","journal-title":"J Clin Oncol"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/73\/19\/1508\/28335619\/ajhp1508.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T12:47:03Z","timestamp":1718801223000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/73\/19\/1508\/5101915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,1]]},"references-count":10,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2016,10,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp150425","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,10,1]]},"published":{"date-parts":[[2016,10,1]]}}}